The European Union's (EU) drug regulator said on Thursday it had started a rolling review of the protein-based COVID-19 vaccine from French biotech firm Valneva , weeks after the EU signed a deal with the company for supplies of the shot.
The logo of Valneva SE is pictured at the company's headquarters in Saint-Herblain, near Nantes, France, September 13, 2021.
Stephane MaheDec 2 - The European Union's drug regulator said on Thursday it had started a rolling review of the protein-based COVID-19 vaccine from French biotech firm ValnevaThe decision to start the real-time review was based on preliminary studies that suggest the vaccine, VLA2001, triggers an antibody response against the coronavirus, the European Medicines Agency said in a
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Latin America is in danger of going back to the old normalAs the covid-19 pandemic recedes, economic stagnation, social discontent and threats to democracy loom
Weiterlesen »
S.Korea hits new COVID-19 record, halts quarantine exemptions to block OmicronSouth Korea's daily coronavirus case numbers rose to a new high on Thursday, as authorities halted quarantine exemptions for fully vaccinated inbound travellers for two weeks in a bid to fend off the Omicron variant.
Weiterlesen »
First U.S. case of omicron variant is found in CaliforniaThe omicron Covid variant has been detected in California, the first confirmed U.S. case. The omicron variant of the coronavirus was first discovered in southern Africa.
Weiterlesen »